Benztropine Mesylate Tablet
Product Images NDC 72162-1154

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benztropine Mesylate (NDC 72162-1154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

This Is An Image Of The Structural Formula For Benztropine. (Benztropinemestab 1)

FDA Label Image

Label (Lbl721621154)

Label (Lbl721621154)
Benztropine Mesylate Tablets, USP is a medication used for the treatment of Parkinsonism and drug-induced extrapyramidal disorders. It contains 2 mg of Benztropine Mesylate, USP per tablet and is recommended for the usual adult dose of 1 to 2 mg per day for parkinsonism and 1 to 4 mg once or twice daily for drug-induced extrapyramidal disorders. The medication should be kept out of children's reach and dispensed in a well-closed container. It should be stored between 20° to 25°C (68° to 77°F). The tablets come in a bottle containing 100 tablets. The drug is manufactured by Par Formulations Private Limited and relabeled by Bryant Ranch Prepack, Inc. This medication is only available with a prescription (Rx only).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.